Profil
Mr. Yi Bo Cao is on the Board of Directors at Suzhou Tongxin Medical Equipment Co., Ltd., VISEN Pharmaceuticals (Shanghai) Co., Ltd., VISEN Pharmaceuticals, Beijing Microread Genetics Co., Ltd., Insight Lifetech Co., Ltd. and Hangzhou New Trials Medical Technology Co., Ltd. Mr. Cao was previously employed as a Managing Director by Vivo Ventures LLC.
He received his undergraduate degree from Peking University and a graduate degree from Peking University.
Aktive Positionen von Yi Bo Cao
| Unternehmen | Position | Beginn |
|---|---|---|
| VISEN PHARMACEUTICALS | Direktor/Vorstandsmitglied | 08.01.2021 |
Insight Lifetech Co., Ltd.
Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Develops and manufactures medical devices for precision diagnosis & therapy | Direktor/Vorstandsmitglied | 15.10.2018 |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
VISEN Pharmaceuticals (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops endocrine disease therapies | Direktor/Vorstandsmitglied | 01.05.2021 |
Beijing Microread Genetics Co., Ltd.
Beijing Microread Genetics Co., Ltd. Medical SpecialtiesHealth Technology Develops test reagents for clinical, forensic, agricultural, animal husbandry and research fields | Direktor/Vorstandsmitglied | 01.12.2020 |
Hangzhou New Trials Medical Technology Co., Ltd.
Hangzhou New Trials Medical Technology Co., Ltd. Information Technology ServicesTechnology Services Provides medical technology services | Direktor/Vorstandsmitglied | - |
Suzhou Tongxin Medical Equipment Co., Ltd.
Suzhou Tongxin Medical Equipment Co., Ltd. Medical SpecialtiesHealth Technology Researches and develops artificial heart assist devices | Direktor/Vorstandsmitglied | 01.05.2021 |
Ehemalige bekannte Positionen von Yi Bo Cao
| Unternehmen | Position | Ende |
|---|---|---|
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life science sectors. It provides financing for early stage, growth stage, buyouts, spin-offs and restructurings. The firm also acquires controlling interest. It acts as lead investor and also makes co-investments. | Vorstandsvorsitzender | 01.07.2017 |
Ausbildung von Yi Bo Cao
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life science sectors. It provides financing for early stage, growth stage, buyouts, spin-offs and restructurings. The firm also acquires controlling interest. It acts as lead investor and also makes co-investments. | Finance |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Suzhou Tongxin Medical Equipment Co., Ltd.
Suzhou Tongxin Medical Equipment Co., Ltd. Medical SpecialtiesHealth Technology Researches and develops artificial heart assist devices | Health Technology |
Insight Lifetech Co., Ltd.
Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Develops and manufactures medical devices for precision diagnosis & therapy | Health Technology |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
VISEN Pharmaceuticals (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops endocrine disease therapies | Health Technology |
Beijing Microread Genetics Co., Ltd.
Beijing Microread Genetics Co., Ltd. Medical SpecialtiesHealth Technology Develops test reagents for clinical, forensic, agricultural, animal husbandry and research fields | Health Technology |
VISEN Pharmaceuticals
VISEN Pharmaceuticals Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes paradigm-shifting endocrine therapies | Health Technology |
Hangzhou New Trials Medical Technology Co., Ltd.
Hangzhou New Trials Medical Technology Co., Ltd. Information Technology ServicesTechnology Services Provides medical technology services | Technology Services |
















